Welcome to our dedicated page for Lumexa Imaging Holdings news (Ticker: LMRI), a resource for investors and traders seeking the latest updates and insights on Lumexa Imaging Holdings stock.
Lumexa Imaging Holdings, Inc. reports developments tied to its nationwide outpatient medical imaging platform. The company operates diagnostic imaging centers and provides radiology interpretation services, with imaging modalities that include MRI, CT, PET, X-ray, ultrasound and mammography.
Recurring LMRI news covers financial and operating results, conference-call schedules, de novo center openings, joint venture and health-system relationships, leadership appointments, investor conference participation and clinical quality initiatives. Company updates also address growth strategy, advanced imaging volume trends, payer-network activity, balance-sheet actions and the technology used to support patient engagement in radiology reporting.
Lumexa Imaging (NASDAQ: LMRI) priced its initial public offering of 25,000,000 shares of common stock at $18.50 per share, with a 30‑day underwriter option for up to 3,750,000 additional shares.
The Common Stock is expected to begin trading on the Nasdaq Global Select Market under the symbol LMRI on December 11, 2025, and the offering is expected to close on December 12, 2025, subject to customary closing conditions. The registration statement on Form S‑1 was declared effective by the SEC on December 10, 2025.